Frederique Lisacek from SIB Swiss Institute of Bioinformatics, discusses the experimental approaches towards Glycoscience and emphasises the need for collecting and integrating glyco-related information.
The "COVID pill" by Merck, found to halve virus hospitalisation and death rates, will be sold in the US at $712 per treatment - while costing $17.74 to produce.
Paul Ekins, Professor of Resources and Environmental Policy, University College London, tells us about UCL’s COP26 Campaign ‘Together for Climate Action’.
Dave Crispin, CEO of Crispin Associates (UK) Ltd, continues discussions around the role MFDs, photocopiers and printers play in the ‘sustainable’ 2021 office.
Open Access Government explore why it is important for the United States Geological Survey (USGS) to conduct scientific research and development regarding the Earth and its everchanging processes.
Open Access Government uncover how air traffic management is an essential part of European air transport and aviation, connecting cities and people as well as boosting jobs and growth.
Investigating the current and future health priorities of Japan’s Ministry of Health, Labour and Welfare, including an increasing focus on cancer research.
Experts Diane Bunn, Ellice Parkinson and Lee Hooper discuss the problem of dehydration particularly in care homes, first of all asking us to grab a coffee, tea, water, or juice before reading on...
Europe ensures it implements circularity and restores biodiversity, according to Commissioner for Environment, Oceans and Fisheries Virginijus Sinkevičius.
In the latest interview with Open Access Government, the National Center of Meteorology tell us more about their priority areas, such as the importance of earthquake monitoring.
Open Access Government zeroes in on some of the most powerful telescopes in the world – specifically the promise of new discoveries in the Division of Astronomical Sciences (AST) Vera Rubin Observatory.
A look at the work of the European Commission’s department on mobility and transport, efforts to secure a more sustainable future for international aviation.
We reflect on the work of the Molecular and Cellular Biosciences division (MCB), especially in context of the “complex biological web” of a global pandemic.
